Clinical Trials Browser

Recruiting × Klatskin Tumor × Radiosurgery × Clear all

NCT07030140 2026-05-01

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06493734 2025-07-15

STRONG II

Phase NA Recruiting

Gastrointestinal

Klatskin Tumor